Ji-Hwan Bae

Medical Affairs Department, Daiichi Sankyo Korea Co., Ltd., Seoul, South Korea, Republic of Korea

Poster(s):

• (B-289) Bleeding Risk During Use of Non-vitamin K Antagonist Oral Anticoagulants with Telmisartan versus Olmesartan in Patients with Non-Valvular Atrial Fibrillation
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET